In proof-of-concept studies, NNMT inhibitors (NNMTis) have demonstrated promise as potential treatments for obesity and obesity-related metabolic comorbidities (e.g., T2D, fatty liver) 8,9,13
The logic is base-code-plus-upgrade: 45378 is the base code, and when the gastroenterologist performs any intervention during the procedure, the code upgrades to the specific therapeutic CPT that describes what was done
By incorporating a precise ratio of four extensively researched peptides into a single lyophilised vial, this complex allows investigators to observe a broad spectrum of cellular events simultaneously
However, despite these trials, BPC-157 lacks FDA approval, raising concerns about its safety and efficacy due to insufficient clinical testing